Usual Blood Pressure and Risk of New-Onset Diabetes: Evidence From 4.1 Million Adults and a Meta-Analysis of Prospective Studies

Overview

Journal J Am Coll Cardiol

Specialty Cardiology & Vascular Diseases

Date 2015 Oct 3

PMID 26429079

Citations 93

Authors

Connor A Emdin

Simon G Anderson

Mark Woodward

Kazem Rahimi

Affiliations

Soon will be listed here.

Abstract

Background: Reliable quantification of the association between blood pressure (BP) and risk of type 2 diabetes is lacking.

Objectives: This study sought to determine the association between usual BP and risk of diabetes, overall and by participant characteristics.

Methods: A cohort of 4.1 million adults, free of diabetes and cardiovascular disease, was identified using validated linked electronic health records. Analyses were complemented by a meta-analysis of prospective studies that reported relative risks of new-onset diabetes per unit of systolic blood pressure (SBP).

Results: Among the overall cohort, 20 mm Hg higher SBP and 10 mm Hg higher diastolic BP were associated with a 58% and a 52% higher risk of new-onset diabetes (hazard ratio: 1.58; 95% confidence interval [CI]: 1.56 to 1.59; and hazard ratio: 1.52; 95% confidence interval: 1.51 to 1.54), respectively. There was no evidence of a nadir to a baseline BP of 110/70 mm Hg. The strength of the association per 20 mm Hg higher SBP declined with age and with increasing body mass index. Estimates were similar even after excluding individuals prescribed antihypertensive or lipid-lowering therapies. Systematic review identified 30 studies with 285,664 participants and 17,388 incident diabetes events. The pooled relative risk of diabetes for a 20 mm Hg higher usual SBP across these studies was 1.77 (1.53 to 2.05).

Conclusions: People with elevated BP are at increased risk of diabetes. The strength of the association declined with increasing body mass index and age. Further research should determine if the observed risk is modifiable.

Citing Articles

Classification and identification of risk factors for type 2 diabetes.

Tang S, Zhao X, An X, Sun W, Kang X, Sun Y World J Diabetes. 2025; 16(2):100371.

PMID: 39959280 PMC: 11718467. DOI: 10.4239/wjd.v16.i2.100371.

Cinnamic acid alleviates endothelial dysfunction and oxidative stress by targeting PPARδ in obesity and diabetes.

Bai Y, Tan D, Deng Q, Miao L, Wang Y, Zhou Y Chin Med. 2025; 20(1):13.

PMID: 39856769 PMC: 11760083. DOI: 10.1186/s13020-025-01064-7.

Mediating pathways between attention deficit hyperactivity disorder and type 2 diabetes mellitus: evidence from a two-step and multivariable Mendelian randomization study.

Zhang J, Chen Z, Triatin R, Snieder H, Thio C, Hartman C Epidemiol Psychiatr Sci. 2024; 33:e54.

PMID: 39465621 PMC: 11561680. DOI: 10.1017/S2045796024000593.

Association between dietary fiber intake and chronic kidney disease in adults with and without hypertension in the United States: a cross-sectional study of NHANES 2009-2020.

Zhang C, Yan W, Sun X, Lin F Ren Fail. 2024; 46(2):2415514.

PMID: 39412048 PMC: 11486002. DOI: 10.1080/0886022X.2024.2415514.

Study on risk factors of impaired fasting glucose and development of a prediction model based on Extreme Gradient Boosting algorithm.

Cui Q, Pu J, Li W, Zheng Y, Lin J, Liu L Front Endocrinol (Lausanne). 2024; 15:1368225.

PMID: 39381443 PMC: 11458394. DOI: 10.3389/fendo.2024.1368225.

References

Taylor K, Heneghan C, Farmer A, Fuller A, Adler A, Aronson J . All-cause and cardiovascular mortality in middle-aged people with type 2 diabetes compared with people without diabetes in a large U.K. primary care database. Diabetes Care. 2013; 36(8):2366-71. PMC: 3714501. DOI: 10.2337/dc12-1513. View

Wormser D, White I, Thompson S, Wood A . Within-person variability in calculated risk factors: comparing the aetiological association of adiposity ratios with risk of coronary heart disease. Int J Epidemiol. 2013; 42(3):849-59. PMC: 3733701. DOI: 10.1093/ije/dyt077. View

Lindholm L, Ibsen H, Borch-Johnsen K, Olsen M, Wachtell K, Dahlof B . Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study. J Hypertens. 2002; 20(9):1879-86. DOI: 10.1097/00004872-200209000-00035. View

Taddei S, Virdis A, Ghiadoni L, Sudano I, Salvetti A . Antihypertensive drugs and reversing of endothelial dysfunction in hypertension. Curr Hypertens Rep. 2000; 2(1):64-70. DOI: 10.1007/s11906-000-0061-8. View

Pradhan A, Manson J, Rifai N, Buring J, Ridker P . C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA. 2001; 286(3):327-34. DOI: 10.1001/jama.286.3.327. View

Herrett E, Shah A, Boggon R, Denaxas S, Smeeth L, van Staa T . Completeness and diagnostic validity of recording acute myocardial infarction events in primary care, hospital care, disease registry, and national mortality records: cohort study. BMJ. 2013; 346:f2350. PMC: 3898411. DOI: 10.1136/bmj.f2350. View

Ridker P, Pradhan A, MacFadyen J, Libby P, Glynn R . Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial. Lancet. 2012; 380(9841):565-71. PMC: 3774022. DOI: 10.1016/S0140-6736(12)61190-8. View

Hex N, Bartlett C, Wright D, Taylor M, Varley D . Estimating the current and future costs of Type 1 and Type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs. Diabet Med. 2012; 29(7):855-62. DOI: 10.1111/j.1464-5491.2012.03698.x. View

Swerdlow D, Holmes M, Kuchenbaecker K, Engmann J, Shah T, Sofat R . The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis. Lancet. 2012; 379(9822):1214-24. PMC: 3316968. DOI: 10.1016/S0140-6736(12)60110-X. View

10.

Whiting D, Guariguata L, Weil C, Shaw J . IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 2011; 94(3):311-21. DOI: 10.1016/j.diabres.2011.10.029. View

11.

Chamarthi B, Williams G, Ricchiuti V, Srikumar N, Hopkins P, Luther J . Inflammation and hypertension: the interplay of interleukin-6, dietary sodium, and the renin-angiotensin system in humans. Am J Hypertens. 2011; 24(10):1143-8. PMC: 3807212. DOI: 10.1038/ajh.2011.113. View

12.

Sarwar N, Gao P, Kondapally Seshasai S, Gobin R, Kaptoge S, Di Angelantonio E . Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010; 375(9733):2215-22. PMC: 2904878. DOI: 10.1016/S0140-6736(10)60484-9. View

13.

Sawada S, Lee I, Naito H, Noguchi J, Tsukamoto K, Muto T . Long-term trends in cardiorespiratory fitness and the incidence of type 2 diabetes. Diabetes Care. 2010; 33(6):1353-7. PMC: 2875453. DOI: 10.2337/dc09-1654. View

14.

McMurray J, Holman R, Haffner S, Bethel M, Holzhauer B, Hua T . Effect of valsartan on the incidence of diabetes and cardiovascular events. N Engl J Med. 2010; 362(16):1477-90. DOI: 10.1056/NEJMoa1001121. View

15.

Kaptoge S, Di Angelantonio E, Lowe G, Pepys M, Thompson S, Collins R . C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet. 2009; 375(9709):132-40. PMC: 3162187. DOI: 10.1016/S0140-6736(09)61717-7. View

16.

Herrett E, Thomas S, Schoonen W, Smeeth L, Hall A . Validation and validity of diagnoses in the General Practice Research Database: a systematic review. Br J Clin Pharmacol. 2010; 69(1):4-14. PMC: 2805870. DOI: 10.1111/j.1365-2125.2009.03537.x. View

17.

Erqou S, Kaptoge S, Perry P, Di Angelantonio E, Thompson A, White I . Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. JAMA. 2009; 302(4):412-23. PMC: 3272390. DOI: 10.1001/jama.2009.1063. View

18.

Whitlock G, Lewington S, Sherliker P, Clarke R, Emberson J, Halsey J . Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet. 2009; 373(9669):1083-96. PMC: 2662372. DOI: 10.1016/S0140-6736(09)60318-4. View

19.

Carter B, Einhorn P, Brands M, He J, Cutler J, Whelton P . Thiazide-induced dysglycemia: call for research from a working group from the national heart, lung, and blood institute. Hypertension. 2008; 52(1):30-6. DOI: 10.1161/HYPERTENSIONAHA.108.114389. View

20.

Lewington S, Whitlock G, Clarke R, Sherliker P, Emberson J, Halsey J . Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet. 2007; 370(9602):1829-39. DOI: 10.1016/S0140-6736(07)61778-4. View